Details of the Drug

General Information of Drug (ID: DMJZBXX)

• Drug Name: Ginkgo biloba

Indication

Disease Entry	ICD 11	Status	REF
Alzheimer disease	8A20	Phase 2/3	[1]

• Affected Organisms: Humans and other mammals
• Cross-matching ID:
  UNII: 19FUJ2C58T
  DrugBank ID: DB01381
  TTD ID: D6S9AH

References

• [1] ClinicalTrials.gov (NCT03090516) Clinical Study on Improving the Cognitive Function of Patients With Mild to Moderate Alzheimer's Disease by Using Ginkgo Biloba Dispersible Tablets. U.S.National Institutes of Health.